About elanco animal health inc. - ELAN
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.
ELAN At a Glance
Elanco Animal Health, Inc.
450 Elanco Circle
Indianapolis, Indiana 46221
| Phone | 1-877-352-6261 | Revenue | 4.44B | |
| Industry | Biotechnology | Net Income | 338.00M | |
| Sector | Health Technology | 2024 Sales Growth | 0.498% | |
| Fiscal Year-end | 12 / 2025 | Employees | 9,450 | |
| View SEC Filings |
ELAN Valuation
| P/E Current | 308.505 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 17.817 |
| Price to Sales Ratio | 1.357 |
| Price to Book Ratio | 0.982 |
| Price to Cash Flow Ratio | 11.13 |
| Enterprise Value to EBITDA | 10.951 |
| Enterprise Value to Sales | 2.252 |
| Total Debt to Enterprise Value | 0.444 |
ELAN Efficiency
| Revenue/Employee | 469,735.45 |
| Income Per Employee | 35,767.196 |
| Receivables Turnover | 4.408 |
| Total Asset Turnover | 0.329 |
ELAN Liquidity
| Current Ratio | 2.445 |
| Quick Ratio | 1.248 |
| Cash Ratio | 0.356 |
ELAN Profitability
| Gross Margin | 43.005 |
| Operating Margin | 5.654 |
| Pretax Margin | 10.993 |
| Net Margin | 7.614 |
| Return on Assets | 2.506 |
| Return on Equity | 5.487 |
| Return on Total Capital | 3.207 |
| Return on Invested Capital | 3.00 |
ELAN Capital Structure
| Total Debt to Total Equity | 72.90 |
| Total Debt to Total Capital | 42.163 |
| Total Debt to Total Assets | 35.231 |
| Long-Term Debt to Equity | 71.67 |
| Long-Term Debt to Total Capital | 41.452 |